MedCath (MDTH) Announces Resignation of COO
More News related to MDTH
- Notable Analyst Rating Changes 11/18: CHS, CBRL, MDTH, DIS Upgraded; KO, PEP, K, DT, ESLR Downgraded
- Citi Upgrades Medcath (MDTH) to Hold
- Five MedCath Hospitals Ranked Among Nation's Top 100
- BMO Downgrades MedCath (MDTH) to Market Perform
- Unusual 11 Mid-Day Movers 11/14: FUQI, LVS, ALO, SUTR Higher; MDTH, CY, OEH, SLH Lower
More News related to Management Changes
- B. Riley Downgrades Doral Financial (DRL) to Neutral
- CL King Downgrades Ceragon (CRNT) to Accumulate
- Matrix Upgrades/Downgrades for December 1, 2008
- Raymond James Downgrades Allscripts (MDRX) to Market Perform
- RBC Capital Downgrades Strategic Hotels & Resorts (BEE) to Underperform
MedCath Corporation (Nasdaq: MDTH) announced the resignation of Phil Mazzuca, Executive Vice President and Chief Operating Officer since March 2006. Mazzuca will remain with MedCath for up to 90 days and then assume a post with a private healthcare company. MedCath also announced that Mazzuca's responsibilities will be assumed on an interim basis by O. Edwin French, MedCath's President and Chief Executive Officer and Derek Morkel, Senior Vice President, Operations.
MedCath Corporation (MedCath) is a healthcare provider focused primarily on the diagnosis and treatment of cardiovascular disease.
Related Categories
Management ChangesStocks Mentioned
+0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
